Menarini Group: Pharmaceuticals and Healthcare Company Profile & SWOT ReportiCD ResearchFebruary 6, 2012 21 Pages - SKU: ICDR6793260 |
| Synopsis ICD Research's Menarini Group: Pharmaceuticals and Healthcare Company Profile & SWOT Report contains in depth information and data about the company and its operations. The profile contains a company overview, business description, SWOT analysis, key facts, information on products and services, details of locations and subsidiaries, plus information on key news events affecting the company. Summary ICD Research's Menarini Group: Pharmaceuticals and Healthcare Company Profile & SWOT Report is a crucial resource for industry executives and anyone looking to access key information about Menarini Group. ICD Research's Menarini Group: Pharmaceuticals and Healthcare Company Profile & SWOT Report report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Scope
Menarini Group (Menarini) is one of the leading biopharmaceutical companies in Italy. The company develops and commercializes drug candidates for treating a wide range of diseases. It operates in various therapeutic areas such as oncology, cardiovascular, virology, gastro-intestinal, antibiotics or respiratory system, diabetes, and anti-inflammatory agents or analgesics. It offers products through three divisions, Ethical drugs, OTC drugs and diagnostic products. Menarini, through its subsidiaries and affiliates, operates in European Union, Central America, Central and Eastern European countries, South Africa, Switzerland, and Turkey. Furthermore, it has operations in developing countries such as India, Vietnam, China and Korea. Menarini is headquartered in Florence, Italy. |
Related Markets
Pharmaceuticals Company Reports
- Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2012
- Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
- Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics
- Partnerships, Licensing, Investments and M&A Deals and Trends for March 2012 in Pharmaceuticals
- Contract Research Organizations (CROs) Market to 2018 - Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development Programs

